Secondary amyloidosis is a form of amyloidosis (see this term), that complicates chronic inflammatory disorders (mainly rheumatoid arthritis, see this term) and is characterized by the aggregation and deposition of amyloid fibrils composed of serum amyloid A protein, an acute phase reactant. Although spleen, suprarenal gland, liver and gut are frequent sites of amyloid deposition, the clinical picture is dominated by renal involvement.
Genes related to Aa Amyloidosis
Clinical FeaturesTop most frequent phenotypes and symptoms related to Aa Amyloidosis
- Abnormal heart morphology
- Abdominal pain
- Abnormality of the kidney
And another 20 symptoms. If you need more information about this disease we can help you.
Incidence and onset information— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.
Aa Amyloidosis Is also known as secondary amyloidosis, inflammatory amyloidosis, reactive amyloidosis.
Researches and researchersCurrently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.
Aa Amyloidosis Recommended genes panels
|Panel Name, Specifity and genes Tested/covered|
Familial mediterranean fever.
By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders (Germany).
SAA1, TNFRSF1A, MEFV
By Fulgent Genetics Fulgent Genetics (United States).
You can get up to -6 more panels with our dedicated toolLearn more
Sources and references
You can check the following sources for additional information.ORPHANET Rare Disease Search Engine
If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT; PHARC BLOOD GROUP--LUTHERAN INHIBITOR; INLU DENYS-DRASH SYNDROME; DDS MUSCULAR DYSTROPHY, BECKER TYPE; BMD OROFACIODIGITAL SYNDROME I; OFD1 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE